Philip Auyang, MD
Vascular Surgery · Houston, TXNPI 1114306545
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $35,257 of the $42,663 with a category attached, or 82.6%. It is spread thinly across 42 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations.
Across 415 payments — averaging $102.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Penumbra, Inc.$5K
- Cagent Vascular Inc$5K
- Endologix LLC$4K
- Inari Medical, Inc.$4K
- Silk Road Medical, Inc.$3K
- plus $15K from 36 others
What the payments were for
- Consulting fees$1,0502%
- Speaking & faculty fees$5001%
- Travel & lodging$5,85714%
- Food & beverage$35,25783%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 82 | $6,817 |
| Penumbra, Inc. | 33 | $5,084 |
| Cagent Vascular Inc | 26 | $4,563 |
| Endologix LLC | 32 | $4,334 |
| Inari Medical, Inc. | 25 | $4,022 |
| Silk Road Medical, Inc. | 26 | $3,041 |
| Boston Scientific | 37 | $2,411 |
| Bolton Medical Inc | 16 | $1,966 |
| Aroa Biosurgery Incorporated | 8 | $1,624 |
| W. L. Gore & Associates, Inc. | 22 | $1,495 |
| Angiodynamics, Inc. | 9 | $1,110 |
| Biom'up France SAS | 5 | $640 |
| BD | 6 | $579 |
| Imperative Care, Inc | 5 | $540 |
| Baxter Healthcare | 7 | $534 |
| Johnson & Johnson(2 entities) | 9 | $515 |
| Cook Medical LLC | 11 | $494 |
| Shockwave Medical, Inc | 11 | $457 |
| Abbott | 4 | $303 |
| Davol Inc. | 2 | $248 |
| Surmodics, Inc. | 7 | $216 |
| Mozarc Medical US LLC | 3 | $203 |
| Teleflex LLC | 2 | $186 |
| Stryker | 1 | $166 |
| Organogenesis Inc. | 1 | $154 |
| Bone Support Inc. | 1 | $153 |
| Dilon Technologies, Inc. | 2 | $152 |
| Bard Peripheral Vascular, Inc. | 2 | $105 |
| Mindray DS USA, Inc. | 2 | $94 |
| Atricure, Inc. | 2 | $71 |
| Lemaitre Vascular, Inc. | 2 | $49 |
| KCI USA, Inc. | 1 | $47 |
| Irhythm Technologies, Inc. | 2 | $45 |
| Pfizer | 2 | $44 |
| Solventum Corporation | 2 | $34 |
| Octapharma USA, Inc. | 1 | $31 |
| Livanova USA, Inc. | 1 | $29 |
| Avinger Inc. | 1 | $24 |
| Hydrofera LLC | 1 | $23 |
| Altathera Pharmaceuticals LLC | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$5,231
- Indigo System$4,150
- ENDURANT IIS$3,970
- Serrantor$3,955
- ENROUTE Transcarotid Neuroprotection System$3,064
- ENROUTE Transcarotid Stent$2,887
- CT THROMBECTOMY SYSTEM KIT$2,251
- Alto Abdominal Stent Graft System$1,621
- Torus Stent Graft System$1,205
- ENDOCROSS Device$1,067
- Grafts$932
- ENROUTE .014 Guidewire$890
- ENHANCE Transcarotid Peripheral Access Kit$890
- HemoBlast Bellows$689
- AlphaVac$678
- Ranger$542
- TREO ABDOMINAL STENT-GRAFT SYSTEM$536
- GORE VIABAHN VBX Balloon Expandable Endo$407
- XARELTO$368
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$347
How this compares
$42,663 in reported general payments places this provider in the 85th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 29 | $27,488 |
| EliquisApixaban | 22 | $18,844 |
| ClopidogrelClopidogrel Bisulfate | 89 | $848 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 37 | $236 |
| Cilostazol | 12 | $103 |
| Tramadol Hcl | 24 | $55 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $515 | $27,48829 claims |
| PfizerEliquis | $44 | $18,84422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 347 vascular surgery providers in Texas.
Other vascular surgery in Houston
- Alan LumsdenHouston$742K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Ali AzizzadehHouston$181K
- Steven MaximusHouston$140K
- Samuel LeonardHouston$96K
- Charudatta BavareHouston$72K
- Jayer ChungHouston$42K
- Rana AfifiHouston$41K
- Linda leHouston$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.